Clinical Trials for AP Biosciences

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: AP Biosciences

Clinical Trials (4)

NCT07165067
A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
PHASE1Not yet recruiting
36 participants
Started: Sep 20, 2025 · Completed: Jan 30, 2028
1 condition2 sponsors2 locations
NCT06669975
A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors
PHASE1/PHASE2Recruiting
85 participants
Started: Apr 22, 2025 · Completed: Dec 1, 2027
1 condition1 sponsor3 locations
NCT05473156
A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies
PHASE1/PHASE2Recruiting
168 participants
Started: Jul 24, 2023 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT06723964
A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors
PHASE1Active, not recruiting
35 participants
Started: Mar 30, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location